Novo Nordisk will lose its patent protection on its branded semaglutide drugs Ozempic and Wegovy in Canada after not paying a ...

Clinic Secret is a telehealth provider specializing in prescription therapies for weight loss. It connects patients with U.S.-licensed doctors who review medical information and prescribe medications, ...

Multiple factors are negatively impacting the compounded Semaglutide market. Insurance coverage for GLP-1s, like Wegovy, still varies widely from plan to plan. Demand for Semaglutide and other GLP-1s ...

Online weight-loss company Noom has begun offering smaller doses of compounded versions of Novo Nordisk's Wegovy as the U.S. drugs regulator clamps down on mass production of copies of the in ...

Compounding pharmacies will no longer be allowed to create semaglutide injections, a generic and cheaper version of Ozempic and Wegovy. This comes after a judge rejected a bid by these pharmacies ...

Compounded semaglutide is a non-FDA-approved alternative to products that contain semaglutide, such as Ozempic. Learn how the safety and efficacy of compounded semaglutide compares with Ozempic.

Weight loss clinics, telehealth companies, physicians, and pharmacies that have been prescribing or dispensing compounded GLP-1 medications must prepare for significant changes following the Food ...

Compounded GLP-1s have given rise to a cottage industry offering cheaper weight loss medications to many Americans — but now soon they may be unavailable to most.

1. Did the FDA set deadlines for compounding pharmacies? The FDA says state-licensed compounding pharmacies must immediately stop making most compound versions of GLP-1 drugs based on tirzepatide.

Semaglutide’s presence on the Drug Shortage List allowed physicians, medspas, telehealth companies, pharmacies, and outsourcing facilities greater latitude to make compounded versions of the ...

FDA declared the semaglutide shortage over, marking a win for Novo Nordisk and a big loss for some telehealth companies, at least for now.